Global Enzyme Replacement Therapy Market Growth 2023-2029

Global Enzyme Replacement Therapy Market Growth 2023-2029

Enzyme replacement therapy (ERT) is a medical treatment which replaces an enzyme that is deficient or absent in the body. Usually, this is done by giving the patient an intravenous (IV) infusion of a solution containing the enzyme.
LPI (LP Information)' newest research report, the “Enzyme Replacement Therapy Industry Forecast” looks at past sales and reviews total world Enzyme Replacement Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Enzyme Replacement Therapy sales for 2023 through 2029. With Enzyme Replacement Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Enzyme Replacement Therapy industry.
This Insight Report provides a comprehensive analysis of the global Enzyme Replacement Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Enzyme Replacement Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Enzyme Replacement Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Enzyme Replacement Therapy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Enzyme Replacement Therapy.
The global Enzyme Replacement Therapy market size is projected to grow from US$ 11570 million in 2022 to US$ 29900 million in 2029; it is expected to grow at a CAGR of 29900 from 2023 to 2029.
Global Enzyme Replacement Therapy key players include Johnson & Johnson, Allergan, AbbVie, etc. Global top three manufacturers hold a share about 95%.
North America is the largest market, with a share about 70%, followed by Europe, and Asia-Pacific, both have a share over 25 percent.
In terms of product, Oral Agents is the largest segment, with a share nearly 95%. And in terms of application, the largest application is MPS Disease, followed by Gastrointestinal Diseases, Gaucher Disease, Fabry Disease, etc.
This report presents a comprehensive overview, market shares, and growth opportunities of Enzyme Replacement Therapy market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Injectable Agents
Oral Agents
Segmentation by application
Gaucher Disease
Fabry Disease
MPS Disease
Gastrointestinal Disease
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Sanofi
Takeda
BioMarin
AbbVie
Alexion
Allergan
Horizon Pharma
Johnson & Johnson
Actelion
Recordati Rare Diseases
Pfizer
Digestive Care
Leadiant Biosciences
Key Questions Addressed in this Report
What is the 10-year outlook for the global Enzyme Replacement Therapy market?
What factors are driving Enzyme Replacement Therapy market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Enzyme Replacement Therapy market opportunities vary by end market size?
How does Enzyme Replacement Therapy break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.